Skip to main content
← Back to companies
CellType logo

CellType

2 open
2+ employees

The agentic drug company. We simulate human biology.

YC W26

About the Company

CellType is building foundation models and agent systems for biology.

We are building models that learn from biological data, experiments, and outcomes directly. Our goal is to develop AI systems that are genuinely useful for scientific discovery and drug development.

We work on problems such as preclinical-to-clinical translation, response prediction, biomarker discovery, and reasoning across complex biological datasets. These are technically difficult problems with real scientific and commercial importance.

We are an early team with high standards for technical depth, speed, and ambition. This is a good fit for people who want to work on hard model and systems problems in a domain that matters.

Tech Stack

We are building the infrastructure needed to train and deploy foundation models for biology.

This includes petabyte-scale data pipelines, indexing and retrieval systems over large biological datasets, and multi-node GPU training infrastructure for model training, post-training, and evaluation. We care about the full path from raw data ingestion to reproducible datasets to efficient distributed training and reliable production systems.

Key technical areas include:

  • large-scale biological data ingestion and processing
  • retrieval, indexing, and search over heterogeneous experimental and molecular datasets
  • dataset validation, reproducibility, and versioning
  • distributed data loading and performance optimization
  • multi-node GPU training and post-training infrastructure
  • observability, debugging, and reliability for ML systems
  • internal platforms and tooling for fast research iteration

We are interested in people who are strong in distributed systems, data infrastructure, ML systems, or large-scale training, and who want to apply that skillset to biology.

Founders

David van Dijk
David van Dijk

Co-Founder & CEO of CellType (W26). Yale Professor, 11,000+ citations. Built biological foundation models with Google. Building the agentic drug company.

Ivan Vrkic
Ivan Vrkic

Co-Founder @ CellType (W26). ML @ Yale & EPFL. Building the next-generation agentic drug company. Co-developed our core technology Cell2Sentence at Yale and published at ICML. Previously led large-scale foundation model training at a biotech startup and built software to control CERN's Large Hadron Collider.

Ready to start your space career at CellType?

Shipping like we're funded. We're not. No affiliation.

Sequoia logo
Y Combinator logo
Founders Fund logo
a16z logo